Metod Miklus
Chief Operating Officer bij DEUTSCHE BIOTECH INNOVATIV AG
Profiel
Metod Miklus is the founder of Marjan Miklus-Stiftung, B.R.A.H.M.S Diagnostika GmbH, Exponat GmbH, ExpoCapital GmbH, and B·R·A·H·M·S GmbH.
He is currently the Chief Operating Officer & Head-Corporate Affairs at Deutsche Biotech Innovativ AG, a Member of the Supervisory Board at AdrenoMed AG and SphingoTec GmbH, and a Member of the Management Board at Marjan Miklus Stiftung zur Förderung der Wissenschaft und.
He holds a doctorate degree from the Technical University of Berlin.
Actieve functies van Metod Miklus
| Bedrijven | Functie | Begin |
|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Chief Operating Officer | - |
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Director/Board Member | - |
| Marjan Miklus Stiftung zur Förderung der Wissenschaft und | Corporate Officer/Principal | - |
SphingoTec GmbH
 SphingoTec GmbH BiotechnologyHealth Technology SphingoTec GmbH develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function. The firm specializes in biomarker discovery and acute care diagnostics. The company was founded by Andreas Bergmann in 2002 and is headquartered in Hennigsdorf, Germany. | Director/Board Member | - |
Eerdere bekende functies van Metod Miklus
| Bedrijven | Functie | Einde |
|---|---|---|
| ExpoCapital GmbH | Founder | - |
| Exponat GmbH | Founder | - |
| B.R.A.H.M.S Diagnostika GmbH | Founder | - |
| Marjan Miklus-Stiftung | Founder | - |
B·R·A·H·M·S GmbH
 B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Founder | - |
Opleiding van Metod Miklus
| Technical University of Berlin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Finance |
| Bedrijven in privébezit | 8 |
|---|---|
B·R·A·H·M·S GmbH
B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Commercial Services |
SphingoTec GmbH
SphingoTec GmbH BiotechnologyHealth Technology SphingoTec GmbH develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function. The firm specializes in biomarker discovery and acute care diagnostics. The company was founded by Andreas Bergmann in 2002 and is headquartered in Hennigsdorf, Germany. | Health Technology |
| Marjan Miklus-Stiftung | Miscellaneous |
| B.R.A.H.M.S Diagnostika GmbH | |
| Exponat GmbH | |
| ExpoCapital GmbH | |
| Marjan Miklus Stiftung zur Förderung der Wissenschaft und | Miscellaneous |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
